Cheap drug trial offers hope for Leprosy's agonizing skin condition
NCT ID NCT03775460
Summary
This study is testing if adding a low-cost drug called methotrexate can help control painful skin flare-ups (ENL) in people with leprosy. It aims to reduce the need for long-term steroid use, which has serious side effects. The trial involves 550 adults with moderate-to-severe ENL across six countries, comparing a year-long methotrexate and steroid regimen against steroids alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHEMA NODOSUM LEPROSUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ALERT
Addis Ababa, Ethiopia
-
Anandaban Hospital
Kathmandu, Nepal
-
Bombay Leprosy Project
Mumbai, India
-
FIOCRUZ
Rio de Janeiro, Brazil
-
Soetomo Hospital
Surabaya, Indonesia
-
TMLI Bangladesh/ DBLM hospital
Dhaka, Bangladesh
-
The Leprosy Mission Trust
Delhi, India
Conditions
Explore the condition pages connected to this study.